Paula Egitto
About Paula Egitto
Paula Egitto is the Global Regulatory Affairs Integrated Oncology Liaison for LATAM at Bristol-Myers Squibb, with over 8 years of experience in various roles at the company.
Current Role at Bristol-Myers Squibb
Paula Egitto is currently serving as the Global Regulatory Affairs - Integrated Oncology Liaison for LATAM at Bristol-Myers Squibb. In this role, she is responsible for overseeing regulatory strategies and liaising between oncology departments and regulatory bodies across Latin America. Her work involves ensuring compliance with local and global regulations, and facilitating communication to streamline regulatory processes.
Professional Experience at Bristol-Myers Squibb
Paula Egitto has accumulated over 8 years of experience at Bristol-Myers Squibb, holding various roles. She worked as a Regulatory Affairs Coordinator in New York in 2016-2017 and served as a Pharmacovigilance Interim Analyst in 2015. Prior to these roles, Paula was a Regulatory Affairs Analyst in Argentina from 2014 to 2015. During her tenure, she has developed extensive expertise in regulatory affairs and pharmacovigilance.
Career at Farmacity
Before her extensive involvement at Bristol-Myers Squibb, Paula Egitto worked at Farmacity as a Pharmacy Responsible from 2008 to 2014. Here, she gained valuable experience in the pharmaceutical retail sector. Her responsibilities included managing pharmacy operations and ensuring compliance with pharmaceutical standards.
Academic Role at Universidad de Buenos Aires
Paula Egitto contributed significantly to academic research and education during her tenure as an Assistant Professor in Cell and Molecular Biology at Universidad de Buenos Aires from 2007 to 2014. In this position, she was involved in teaching and mentoring students while engaging in research activities.
Education at University of Buenos Aires
Paula Egitto studied at the University of Buenos Aires, completing her education from 2006 to 2015. She also attended the Universidad de Buenos Aires / UBA from 2005 to 2013. This educational background has provided her with a strong foundation in biological sciences and regulatory affairs, which she has applied throughout her career.